Cutler Group LP Sorrento Therapeutics, Inc. Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.74 - $1.83 $1,554 - $3,843	-2,100 Reduced 65.63%	1,100 $0
Q3 2022 Oct 25, 2022	BUY	$1.51 - $2.88 $1,963 - $3,744	1,300 Added 68.42%	3,200 $5,000
Q2 2022 Aug 04, 2022	BUY	$1.24 - $2.33 $1,240 - $2,330	1,000 Added 111.11%	1,900 $3,000
Q1 2022 Apr 14, 2022	SELL	$2.0 - $4.9 $4,400 - $10,780	-2,200 Reduced 70.97%	900 $2,000
Q4 2021 Jan 18, 2022	SELL	$4.65 - $7.23 $1,860 - $2,892	-400 Reduced 11.43%	3,100 $14,000
Q3 2021 Oct 26, 2021	SELL	$7.41 - $10.99 $12,597 - $18,683	-1,700 Reduced 32.69%	3,500 $26,000
Q2 2021 Jul 19, 2021	BUY	$6.35 - $10.0 $3,175 - $5,000	500 Added 10.64%	5,200 $50,000
Q4 2020 Jan 21, 2021	BUY	$5.76 - $11.95 $1,670 - $3,465	290 Added 6.58%	4,700 $32,000
Q3 2020 Oct 27, 2020	SELL	$6.17 - $18.82 $10,427 - $31,805	-1,690 Reduced 27.7%	4,410 $49,000
Q2 2020 Jul 22, 2020	BUY	$1.73 - $6.76 $10,034 - $39,208	5,800 Added 1933.33%	6,100 $38,000
Q4 2019 Feb 06, 2020	BUY	$1.45 - $4.17 $435 - $1,251	300 New	300 $1,000
Q2 2018 Aug 10, 2018	SELL	$4.75 - $8.0 $475 - $800	-100 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$4.5 - $9.95 $450 - $994	100 New	100 $0
Q4 2017 Jan 17, 2018	SELL	$1.75 - $3.8 $175 - $380	-100 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$1.63 - $2.0 $163 - $200	100	100 $0

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.